Cott (TSE:PRM – Get Free Report) was upgraded by BMO Capital Markets to a “strong-buy” rating in a research report issued on Monday,Zacks.com reports.
PRM has been the subject of several other research reports. William Blair upgraded shares of Cott to a “strong-buy” rating in a research report on Thursday, October 24th. Raymond James lowered shares of Cott from a “moderate buy” rating to a “hold” rating in a research report on Wednesday, October 2nd.
Check Out Our Latest Research Report on PRM
Cott Stock Up 0.3 %
About Cott
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Read More
- Five stocks we like better than Cott
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- These 3 Airline Stocks Have Analysts Feeling Bullish for 2025
- Stock Analyst Ratings and Canadian Analyst Ratings
- Is Raytheon the Best Defense and Aerospace Stock to Own in 2025?
- How to Calculate Options Profits
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
Receive News & Ratings for Cott Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cott and related companies with MarketBeat.com's FREE daily email newsletter.
